![](https://www.contemporaryhealth.co.uk/wp-content/uploads/2024/06/ozempic-insulin-injection-pen-insulin-cartridge-pen-diabetics-1.jpg)
Innovative obesity drug pemvidutide maintains muscle mass in Altimmune trials
Altimmune, a biotechnology company, recently shared encouraging results from their Phase II MOMENTUM study concerning their investigational obesity treatment, pemvidutide. The study data, which was presented at the 84th Scientific Sessions of the American Diabetes Association, revealed that pemvidutide not only facilitates significant weight loss in adults diagnosed with obesity but also...Read More![](https://www.contemporaryhealth.co.uk/wp-content/uploads/2024/06/shanghai-closeup-nightfall-modern-buildings-financial-center-china.jpg)
India and China to introduce cheaper alternatives to popular obesity medications
As global demand for effective weight-loss medications surges, pharmaceutical companies in India and China are poised to disrupt the market by introducing cheaper versions of established obesity drugs, such as Wegovy. These firms are in the process of developing biosimilars, which are highly similar to original biologic drugs but are typically more affordable. This development is expected to...Read More![](https://www.contemporaryhealth.co.uk/wp-content/uploads/2024/06/mix-different-nuts-wooden-cup-against-background-fabric-from-burlap.jpg)
Nuts can aid in weight loss efforts, research shows
Nuts, often enjoyed as a topping on morning cereal or as a mid-afternoon nibble, may play a pivotal role in effective weight management strategies, according to new research findings. A study conducted by the University of South Australia has found that nuts can be a beneficial component of calorie-restricted diets aimed at weight loss. The research, which synthesised data from seven...Read More![](https://www.contemporaryhealth.co.uk/wp-content/uploads/2024/06/mother-son-sofa-use-smartphone.jpg)
US panel advises intensive behavioural counselling for children with obesity
A panel of experts in the United States has revised its guidance for paediatric obesity screening, with new recommendations highlighting the necessity for intensive behavioural interventions for children over the age of six who have a high body mass index (BMI). This update, issued by the U.S. Preventive Services Task Force, was published in the Journal of the American Medical Association...Read More![](https://www.contemporaryhealth.co.uk/wp-content/uploads/2024/06/blue_bghex_08.jpg)
AI enhances efficiency of artificial pancreas, study confirms
Recent research conducted by the University of Virginia’s Center for Diabetes Technology reveals that incorporating artificial intelligence (AI) into an artificial pancreas system can significantly improve its operational efficiency. This innovative study marks a crucial advancement in the management of type 1 diabetes. The study highlights that an AI-equipped artificial pancreas...Read More![](https://www.contemporaryhealth.co.uk/wp-content/uploads/2024/06/closeup-shot-doctor-with-rubber-gloves-taking-blood-test-from-patient.jpg)
Substantial rise in individuals at risk of type 2 diabetes in England, NHS reports
In a striking development reported by the NHS, the number of people in England identified as being at risk of developing type 2 diabetes has surged by over half a million in just one year. According to the latest data from the National Diabetes Audit, the figures for those diagnosed with non-diabetic hyperglycaemia, commonly referred to as pre-diabetes, rose from 3,065,825 in 2022 to...Read More![](https://www.contemporaryhealth.co.uk/wp-content/uploads/2024/06/young-chubby-woman-sport-workout-harbor-bridge-stretching-legs.jpg)